Table 3.
Questions | Medical directors | Membership | Total | P value |
---|---|---|---|---|
| ||||
What type of mechanical VTE prophylaxis do you use? (Preop and during hospitalization)† | ||||
(SCD) - knee length | 106 (86.9%) | 104 (82.5%) | 210 (84.7%) | .111 |
(SCD) - thigh length | 6 (4.9%) | 6 (4.8%) | 12 (4.8%) | .927 |
TED hose | 3 (2.5%) | 1 (.8%) | 4 (1.6%) | .359 |
TED hose and SCDs | 2 (1.6%) | 11 (8.7%) | 13 (5.2%) | .013* |
Ambulation only | 2 (1.6%) | 2 (1.6%) | 4 (1.6%) | 1.000 |
Other | 3 (2.5%) | 2 (1.6%) | 5 (2%) | .677 |
What type of chemical VTE prophylaxis do you use? (Preop and during hospitalization)† | ||||
Heparin | 56 (39.2%) | 64 (37.2%) | 120 (38.1%) | .805 |
Enoxaparin | 81 (56.6%) | 97 (56.4%) | 178 (56.5%) | .293 |
Apixaban | 2 (1.4%) | 2 (1.2%) | 4 (1.3%) | 1.000 |
Rivaroxaban | 0 (0%) | 2 (1.2%) | 2 (.6%) | .499 |
Fondaparinux | 2 (1.4%) | 2 (1.2%) | 4 (1.3%) | 1.000 |
Other | 2 (1.4%) | 5 (2.9%) | 7 (2.2%) | .310 |
VTE = venous thromboembolism; SCD = sequential compression devices; TED = thromboembolus deterrent.
Data are expressed as n (%).
P value is calculated using Chi-square or Fisher’s exact test when appropriate.
The difference is significant at the .05 level.
Multiple response questions.